Press
Project end of molecular surveillance of SARS-CoV-2 virus variants in Hamburg
Thursday, 20. April 2023Hamburg Surveillance Platform ends after testing 15,967 SARS-CoV-2 samples.
Leibniz ScienceCampus InterACt continues successful research
Thursday, 30. March 2023Senate approves extension of the project "Integrative Analysis of pathogen-induced Compartments"
New research network investigates hormone-regulated inflammatory pathways after influenza infection
Thursday, 23. February 2023Project start FLU-FLAME
LCI Symposium: Compartments in Infection
Friday, 20. January 2023On January 26-27, 2023, international researchers will gather at the Bernhard Nocht Institute for Tropical Medicine to discuss the role of cellular compartments as niches for the survival of infectious agents in the body.
H7N9 avian influenza in humans: sex differences in disease outcome
Monday, 14. November 2022New research shows that H7N9 infections attack the hormonal axis of males but not females
PROVIREX ESTABLISHES THERAPY HUB FOR THE CURE OF HIV IN HAMBURG'S SCIENCE CITY BAHRENFELD
Thursday, 27. October 2022Further procedure of the LIV spin-off PROVIREX is presented
SARS-CoV-2: Antiviral treatment promotes emergence of new variants
Wednesday, 17. August 2022Study published in Cell Reports Medicine
Institute renaming: HPI becomes LIV - Leibniz Institute of Virology
Monday, 09. May 2022Relaunch with new name and logo
New Junior Research Group "Genomics of Retroviral Infections"
Monday, 02. May 2022Dr. Ulrike Lange complements the research spectrum of the institute with her junior research group starting in May 2022
Human Cytomegalovirus: Phase-separated compartments support replication
Wednesday, 09. March 2022Results published in Cell Reports